TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
TPTX
Delisted
TPTX was delisted on the 16th of August, 2022.
190 hedge funds and large institutions have $2.98B invested in Turning Point Therapeutics, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 69 increasing their positions, 67 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
44% less call options, than puts
Call options by funds: $684K | Put options by funds: $1.23M
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
190
Holding in Top 10
1
Calls
$684K
Puts
$1.23M
Top Buyers
| 1 | +$34.9M | |
| 2 | +$26M | |
| 3 | +$23.6M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$15.6M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$11M |
Top Sellers
| 1 | -$60.4M | |
| 2 | -$36.3M | |
| 3 | -$31.2M | |
| 4 |
Jennison Associates
New York
|
-$19.8M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$12.9M |